Overstrip
Problem
Ovarian cancer is often detected at advanced stages (3rd or 4th) due to its subtle and nonspecific symptoms, such as bloating, abdominal pain, loss of appetite, and frequent urination. These symptoms are commonly mistaken for other less serious conditions, leading to delayed diagnosis and reduced effectiveness of treatment. As the second deadliest cancer among women worldwide, ovarian cancer has a significant impact, with 320,000 new cases diagnosed globally each year, including 2,000 in Turkey alone. Early diagnosis is crucial for improving treatment outcomes, yet current methods fall short in identifying the disease in its early stages. This gap in early detection represents a critical challenge that Overstrip aims to address.
Solution
Overstrip offers an innovative rapid diagnostic kit that revolutionizes the early detection of ovarian cancer. By using just two drops of blood from a finger prick, our kit delivers accurate results within 15 minutes, achieving over 97% accuracy. This quick and easy-to-use solution addresses the critical need for early diagnosis, enabling timely treatment and significantly improving survival rates. Overstrip's technology empowers women and healthcare providers with a reliable tool to detect ovarian cancer at its earliest and most treatable stages, overcoming the limitations of traditional diagnostic methods.
Want to connect with Overstrip?
Sign up on StartupDeal to see the full profile, compare startups with AI and reach the team.